AKAN
Akanda Corp. (NASDAQ)
Healthcare — Drug Manufacturers - Specialty & Generic
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
None
$13.44
$-0.09 (-1.97%)
Sign in to add AKAN to a watchlist or set price alerts.
Price History
Fundamentals
| Market Cap | $7.23M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-15065.55 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 48.8 |
| Beta | 14.13 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | - |
| 52-Week Low | - |
| 50-Day Avg | - |
| 200-Day Avg | - |
| Avg Volume | - |
| Volume | - |
Performance Analysis
NEUTRALAKAN presents a mixed picture with both positive and negative indicators.
~
RSI at 48.8 is in neutral territory.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 01, 2026 15:01 UTC
Back to Screener Export Report